Active targeting makes use of the overexpression of certain cell surface receptors and antigens in cancer cells, aiming at increasing NP accumulation in tumor tissues and simultaneously enhancing selective uptake via receptor-mediated endocytosis [10,11,28]. Here, CD177 is linked to neoplasm.